News
Archive
Ventyx Biosciences reports clinical data for its NLRP3 inhibitor portfolio and provides pipeline updates at virtual investor event
NorthSea Therapeutics initiates Phase 2A trial of Orziloben (NST-6179) in Intestinal Failure-Associated Liver Disease (IFALD)
Resolve Therapeutics announces publication of Lupus clinical trial results
biomodal delivers the 6-base genome with a powerful new multiomic solution, duet evoC
InvestEU in Belgium: EIB venture debt for bone therapy innovator Novadip
Repeated Signal Solutions, Inc. and Avari Wireless Inc. announce Enhanced ERCES Monitoring
Back To News
October 17, 2017
TigerConnect
Provider of a texting solution that is easy to use, flexible, easy to learn, and HIPAA (Health Insurance Portability and Accountability Act of 1996) compliant.